David J. Woodhouse, Ph.D.
Director at Surrozen.
Raised on Surrozen filings
$76.4M
of $175M offered across 1 Form D filing
- Form D filings
- 1
- Teammates
- 10
- Last filing
- Apr 8, 2025
Company
Wnt-activating antibodies for tissue repair
- Investors
- 29
- Founded
- 2021
- Still open
- $98.6M
Surrozen filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Apr 8, 2025 | Equity | $76.4M/ $175M | Form D |
- EquityFiled Apr 8, 2025Form D$76.4M/ $175M
Works with
Charles O. WilliamsChief Financial Officer and COO, Form D signerForm D signerYang Li, Ph.D.Executive OfficerMary Haak-Frendscho, Ph.D.DirectorShao-Lee Lin, M.D., Ph.D.DirectorAnna Berkenblit, M.D.DirectorChristopher ChaiDirectorCraig ParkerExecutive Officer, DirectorEric BjerkholtDirectorMace Rothenberg, M.D.DirectorTim Kutzkey, Ph.D.Director
